Iterum Therapeutics plc (ITRM) has a market capitalization of $1.6M and trades at $0.03. The 52-week range is 0.022-1.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.26.
The stock has a beta of 3.01, operates in the Healthcare sector.
